Moderna is recruiting big participants for Nova 301, its Phase 3 objective proceedings evaluating an investigational norovirus vaccine called mRNA-1403.
Jakub Porzycki/NurPhoto/Getty Images
Moderna is recruiting big participants for Nova 301, its Phase 3 objective proceedings evaluating an investigational norovirus vaccine called mRNA-1403.
Jakub Porzycki/NurPhoto/Getty Images